Barclays’s Stryker SYK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-15,600
| Closed | -$5.62M | – | 5541 |
|
|
2024
Q4 | $5.62M | Hold |
15,600
| – | – | ﹤0.01% | 2045 |
|
|
2024
Q3 | $5.64M | Buy |
+15,600
| New | +$5.38M | ﹤0.01% | 1990 |
|
|
2024
Q1 | – | Sell |
-1,000
| Closed | -$299K | – | 5353 |
|
|
2023
Q4 | $299K | Buy |
+1,000
| New | +$281K | ﹤0.01% | 4206 |
|
|
2023
Q3 | – | Sell |
-142,800
| Closed | -$43.6M | – | 4702 |
|
|
2023
Q2 | $43.6M | Buy |
+142,800
| New | +$41.2M | 0.03% | 489 |
|
|
2021
Q1 | – | Sell |
-31,300
| Closed | -$7.67M | – | 5170 |
|
|
2020
Q4 | $7.67M | Buy |
31,300
+20,000
| +177% | +$4.53M | ﹤0.01% | 1288 |
|
|
2020
Q3 | $2.35M | Hold |
11,300
| – | – | ﹤0.01% | 1961 |
|
|
2020
Q2 | $2.04M | Sell |
11,300
-17,700
| -61% | -$3.27M | ﹤0.01% | 2111 |
|
|
2020
Q1 | $4.83M | Sell |
29,000
-37,900
| -57% | -$7.41M | ﹤0.01% | 1501 |
|
|
2019
Q4 | $14M | Buy |
66,900
+39,600
| +145% | +$8.22M | 0.01% | 1164 |
|
|
2019
Q3 | $5.91M | Buy |
27,300
+23,500
| +618% | +$5.04M | ﹤0.01% | 1703 |
|
|
2019
Q2 | $781K | Sell |
3,800
-8,400
| -69% | -$1.6M | ﹤0.01% | 3936 |
|
|
2019
Q1 | $2.41M | Sell |
12,200
-15,300
| -56% | -$2.75M | ﹤0.01% | 2371 |
|
|
2018
Q4 | $4.31M | Buy |
27,500
+21,900
| +391% | +$3.66M | ﹤0.01% | 1696 |
|
|
2018
Q3 | $995K | Buy |
5,600
+2,000
| +56% | +$341K | ﹤0.01% | 3624 |
|
|
2018
Q2 | $608K | Sell |
3,600
-54,600
| -94% | -$9.18M | ﹤0.01% | 3761 |
|
|
2018
Q1 | $9.37M | Sell |
58,200
-194,800
| -77% | -$31.4M | 0.01% | 1207 |
|
|
2017
Q4 | $39.2M | Buy |
253,000
+182,400
| +258% | +$27.8M | 0.03% | 503 |
|
|
2017
Q3 | $10M | Buy |
70,600
+13,000
| +23% | +$1.86M | 0.01% | 1054 |
|
|
2017
Q2 | $7.99M | Buy |
57,600
+53,700
| +1,377% | +$7.37M | 0.01% | 1123 |
|
|
2017
Q1 | $513K | Sell |
3,900
-121,500
| -97% | -$15.3M | ﹤0.01% | 3381 |
|
|
2016
Q4 | $15M | Buy |
125,400
+3,400
| +3% | +$391K | 0.02% | 742 |
|
|
2016
Q3 | $14.2M | Buy |
122,000
+3,400
| +3% | +$396K | 0.02% | 687 |
|
|
2016
Q2 | $14.2M | Buy |
118,600
+114,700
| +2,941% | +$12.8M | 0.02% | 666 |
|
|
2016
Q1 | $417K | Sell |
3,900
-10,400
| -73% | -$1.03M | ﹤0.01% | 3302 |
|
|
2015
Q4 | $1.32M | Sell |
14,300
-1,100
| -7% | -$105K | ﹤0.01% | 2367 |
|
|
2015
Q3 | $1.45M | Sell |
15,400
-42,800
| -74% | -$4.24M | ﹤0.01% | 2398 |
|
|
2015
Q2 | $5.53M | Sell |
58,200
-692,600
| -92% | -$65.6M | 0.01% | 1414 |
|
|
2015
Q1 | $69.1M | Buy |
750,800
+19,400
| +3% | +$1.81M | 0.08% | 232 |
|
|
2014
Q4 | $68.8M | Buy |
731,400
+598,300
| +450% | +$53.1M | 0.07% | 248 |
|
|
2014
Q3 | $10.6M | Buy |
133,100
+105,400
| +381% | +$8.67M | 0.01% | 1132 |
|
|
2014
Q2 | $2.33M | Buy |
27,700
+3,300
| +14% | +$269K | ﹤0.01% | 2440 |
|
|
2014
Q1 | $1.98M | Sell |
24,400
-207,100
| -89% | -$16.5M | ﹤0.01% | 2560 |
|
|
2013
Q4 | $17.4M | Buy |
231,500
+2,100
| +0.9% | +$153K | 0.02% | 844 |
|
|
2013
Q3 | $15.4M | Sell |
229,400
-81,400
| -26% | -$5.62M | 0.02% | 836 |
|
|
2013
Q2 | $20.1M | Buy |
+310,800
| New | +$20.6M | 0.03% | 643 |
|
Other funds holding SYK
VCM
GT
VPM
Barclays's SYK Position: Q1 2026 in Review
Barclays reduced its Stryker (SYK) stake by 12% in Q1 2026, selling an estimated $50.8M and leaving 1,027,154 shares worth $338M. The position accounts for 0.08% of the portfolio, ranked #179.
Barclays first reported a position in SYK in Q2 2013 and has held it in 52 quarters since. The position peaked at $411M in Q4 2025. 2,295 funds tracked by Wall St. Rank hold SYK as of Q1 2026.
- Barclays held 1,027,154 shares of Stryker worth $338M as of Q1 2026.
- Barclays sold 141,502 Stryker shares in Q1 2026, an estimated $50.8M.
- Stryker made up 0.08% of Barclays's portfolio in Q1 2026, its #179 holding.
- Barclays first reported a position in Stryker in Q2 2013 and has held it in 52 quarters since.
- Barclays's Stryker position peaked at $411M in Q4 2025.
- 2,295 funds tracked by Wall St. Rank held Stryker as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.